What is Brightseed?
Founded in 2017 and headquartered in California, Brightseed operates at the intersection of artificial intelligence and biosciences. The company leverages its proprietary AI platform to discover and develop natural compounds that can significantly impact human health. By analyzing vast datasets of natural products, Brightseed aims to unlock novel solutions for a range of health and wellness challenges, positioning itself as a leader in the burgeoning field of data-driven natural product innovation. Its mission to 'illuminate nature' suggests a deep commitment to harnessing the power of the natural world through advanced technology.
How much funding has Brightseed raised?
Brightseed has raised a total of $95M across 2 funding rounds:
Series A
$27M
Series B
$68M
Series A (2020): $27M with participation from CGC Ventures, Lewis & Clark AgriFood Fund II, Horizons Ventures, and Seed 2 Growth Ventures
Series B (2022): $68M led by Temasek
Key Investors in Brightseed
Temasek
Temasek, a global investment company founded in 1974 and headquartered in Singapore, is known for its generational investment approach, seeking to make a positive impact with a long-term perspective.
Lewis & Clark AgriFood Fund II
Lewis & Clark AgriFood Fund II is a late-stage growth equity fund specializing in the AgriFood sector, focusing on tech-enabled, sustainable companies and leveraging deep sector expertise.
Horizons Ventures
Horizons Ventures invests in deep science and technology aimed at advancing humanity, supporting innovative projects with the potential for transformative change in science and technology sectors.
What's next for Brightseed?
With the recent influx of major strategic capital, Brightseed is poised for accelerated growth and expansion. The company is likely to focus on scaling its research and development efforts, further refining its AI capabilities, and potentially broadening its product pipeline. This significant investment suggests a strategic push towards commercialization and market penetration, aiming to translate its scientific discoveries into tangible health solutions. The enterprise-level nature of the funding indicates a focus on significant operational scaling and market leadership, positioning Brightseed to address larger health challenges and capture substantial market share in the coming years.
See full Brightseed company page
